Katarzyna C.
- Country
- Poland
- Department
- N/A
Research Overview
- Efficacy and safety of zenagamtide versus semaglutide in participants with overweight or obesity and type 2 diabetes
- A 40-Week Randomized Study Evaluating the Efficacy and Safety of Weekly Insulin Icodec/Semaglutide Versus Daily Insulin Glargine in Type 2 Diabetes Patients
- Efficacy and Safety Comparison of Once-Weekly Insulin Icodec Versus Once-Daily Insulin Glargine U100 with Insulin Aspart in Adults with Type 1 Diabetes
Data & Insights
Has run more than one trial at 38 of 296 partner sites.
Specializations
Diabetes Management
This investigator specializes in advancing treatment options for type 2 diabetes, with particular focus on innovative insulin therapy approaches. Their research encompasses the evaluation of novel combination treatments that aim to improve glycemic control in diabetic patients.
- Weekly insulin combinations
- Glycemic control optimization
- Comparative insulin therapies
The investigator's work involves exploring treatment alternatives for patients inadequately controlled on oral antidiabetic medications.
Therapeutic Innovation
Their research focuses on evaluating combination therapies that merge different therapeutic mechanisms, specifically investigating the clinical potential of combined insulin icodec and semaglutide formulations.
- Novel drug combinations
- Long-acting insulin formulations
- Treatment optimization strategies
The investigator examines innovative approaches to reduce treatment burden through extended-interval dosing regimens.
Clinical Outcomes
The investigator's work centers on assessing therapeutic efficacy through comprehensive evaluation of glycemic control markers and treatment responses in diabetes management.
- Glycemic control assessment
- Treatment comparison studies
- Long-term outcome evaluation
Their research emphasizes the measurement of clinical outcomes in diabetes treatment through validated biomarkers.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.